Founded in 1898 by the business community, Liverpool School of Tropical Medicine (LSTM) was the first in the world to conduct on-site research of tropical diseases. Sir Ronald Ross of LSTM was the first British winner of the Nobel Prize for his discovery of the link between mosquitoes and malaria. LTSM scientists are credited for discoveries and treatments of sleeping sickness, elephantiasis, river blindness and recently began monumental work to sequester and treat meningitis and sleeping sickness in Africa. LSTM opened the Centre for Tropical and Infectious Disease in January 2008. CTID is a state-of-the-art research facility in Liverpool which houses a variety of consortiums related to the study of Malaria.
Some content from Wikipedia, licensed under CC BY-SA
Subscribe to rss feed
A large LSTM-led trial confirms new antimalarial, dihydroartemisinin-piperaquine, is more effective at preventing malaria than current WHO recommended treatment but does not improve adverse birth outcomes.
Mar 13, 2023
0
72
Snakebite is one of the world's biggest hidden health problems with up to 138 000 victims dying every year, and around 400 000 victims left with permanent physical disabilities or disfigurements. Those most affected live ...
May 6, 2020
1
374
LSTM's Professor Joseph Valadez is senior author on a new study published today in the Proceedings of the National Academy of Sciences, which outlines proposals for a more accurate estimator of health data.
Dec 6, 2018
0
13
LSTM's Dr. Adam Roberts is a co-author on a new paper published in Nature Communications which reports conserved collateral susceptibility to antibiotics in the human pathogen Escherichia coli.
Sep 10, 2018
0
44
LSTM's Dr. Maxine Caws is co-lead investigator on an advanced genetics study published in Nature Genetics, which has shown that a virulent strain of tuberculosis (TB) has adapted to transmit among young adults in Ho Chi Minh ...
May 22, 2018
0
46
Researchers from LSTM's Research Centre for Drugs and Diagnostics have found a way of significantly reducing the treatment required for lymphatic filariasis and onchocerciasis from several weeks to seven days. By targeting ...
Oct 24, 2017
0
5
Scientists from LSTM's Research Centre for Drugs and Diagnostics (RCDD) have described in a paper published today in Scientific Reports, a new way of screening potential treatments for Tuberculosis (TB) which may assist in ...
Mar 29, 2017
0
26
Researchers from LSTM, in collaboration with researchers in Kenya and the U.S., have been investigating options for girls and young women in low-and-middle-income countries to manage menstruation with comfort and dignity ...
Oct 17, 2023
0
0
Snakebite envenoming is a priority neglected tropical disease (NTD), and is responsible for around 94,000 deaths each year, mostly in Asia and sub-Saharan Africa. Clinical trials used to test treatments and outcomes in this ...
Jan 31, 2023
0
8
The Ministry of Health in Uganda and partners, including LSTM, are celebrating the elimination of Gambian sleeping sickness following the recent announcement from the World Health Organization (WHO).
Oct 25, 2022
0
20
